Equities analysts predict that Keurig Dr Pepper Inc (NYSE:KDP) will post sales of $2.83 billion for the current quarter, according to Zacks. Three analysts have issued estimates for Keurig Dr Pepper’s earnings, with the highest sales estimate coming in at $2.93 billion and the lowest estimate coming in at $2.68 billion. Keurig Dr Pepper posted sales of $1.74 billion during the same quarter last year, which would indicate a positive year over year growth rate of 62.6%. The business is scheduled to report its next quarterly earnings results on Wednesday, October 24th.
On average, analysts expect that Keurig Dr Pepper will report full year sales of $11.00 billion for the current financial year, with estimates ranging from $10.83 billion to $11.13 billion. For the next fiscal year, analysts expect that the business will report sales of $11.20 billion, with estimates ranging from $10.95 billion to $11.42 billion. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that cover Keurig Dr Pepper.
Keurig Dr Pepper (NYSE:KDP) last announced its quarterly earnings results on Wednesday, August 8th. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $1.01. The firm had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $2.85 billion. Keurig Dr Pepper had a net margin of 15.98% and a return on equity of 39.52%. The company’s quarterly revenue was up 5.0% on a year-over-year basis.
A number of research analysts have commented on the stock. Macquarie set a $24.00 price target on shares of Keurig Dr Pepper and gave the stock a “hold” rating in a research note on Friday. ValuEngine cut shares of Keurig Dr Pepper from a “sell” rating to a “strong sell” rating in a research note on Thursday, August 2nd. Guggenheim assumed coverage on shares of Keurig Dr Pepper in a research note on Thursday, September 13th. They set a “neutral” rating and a $22.00 price target for the company. Zacks Investment Research upgraded shares of Keurig Dr Pepper from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 18th. Finally, Citigroup raised their price target on shares of Keurig Dr Pepper from $15.46 to $26.00 and gave the stock a “neutral” rating in a research note on Friday, August 10th. Eight equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Keurig Dr Pepper presently has an average rating of “Hold” and an average target price of $25.38.
Shares of KDP opened at $23.04 on Friday. The stock has a market cap of $32.18 billion, a price-to-earnings ratio of 5.08, a price-to-earnings-growth ratio of 1.33 and a beta of 0.74. The company has a debt-to-equity ratio of 1.52, a current ratio of 0.93 and a quick ratio of 0.75. Keurig Dr Pepper has a 12 month low of $20.46 and a 12 month high of $126.65.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 19th. Stockholders of record on Friday, October 5th will be issued a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 2.60%. The ex-dividend date of this dividend is Thursday, October 4th. Keurig Dr Pepper’s payout ratio is 13.22%.
In other news, Director Robert S. Singer acquired 10,000 shares of the company’s stock in a transaction dated Friday, August 10th. The stock was bought at an average price of $23.75 per share, with a total value of $237,500.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Maria A. Sceppaguercio-Gever acquired 49,638 shares of the company’s stock in a transaction dated Thursday, September 13th. The shares were purchased at an average cost of $23.91 per share, with a total value of $1,186,844.58. The disclosure for this purchase can be found here. In the last ninety days, insiders have bought 185,270 shares of company stock valued at $4,338,850. Company insiders own 0.58% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the company. Public Employees Retirement System of Ohio acquired a new stake in shares of Keurig Dr Pepper in the second quarter valued at approximately $8,695,000. TradeLink Capital LLC acquired a new stake in shares of Keurig Dr Pepper in the second quarter valued at approximately $2,806,000. Cerebellum GP LLC acquired a new stake in shares of Keurig Dr Pepper in the third quarter valued at approximately $188,000. Marshall Wace LLP acquired a new stake in shares of Keurig Dr Pepper in the second quarter valued at approximately $3,746,000. Finally, State of Alaska Department of Revenue acquired a new stake in shares of Keurig Dr Pepper in the third quarter valued at approximately $17,663,000. 11.55% of the stock is owned by institutional investors.
About Keurig Dr Pepper
Keurig Dr Pepper Inc engages in the brewing system and specialty coffee businesses in the United States and Canada. The company sources, produces, and sells coffee, hot cocoa, teas, and other beverages in K-Cup, Vue, Rivo, K-Carafe, and K-Mug pods brands; coffee in traditional packaging, including bags and fractional packs; and other specialty beverages in pods.
Featured Story: How to Profit and Limit Losses With Stop Orders
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.